Wave Life Sciences Ltd. financial data

Symbol
WVE on Nasdaq
Industry
Pharmaceutical Preparations
Location
7 Straits View, #12 00, Marina One East Tower, Singapore, Singapore
State of incorporation
Singapore
Fiscal year end
December 31
Former names
Wave Life Sciences Pte Ltd (to 11/2/2015)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 122 % -21.4%
Debt-to-equity 4.11K %
Return On Equity -1.4K % -462%
Return On Assets -32 % +49.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 125M shares +26%
Common Stock, Shares, Outstanding 122M shares +24.3%
Entity Public Float 259M USD +26%
Common Stock, Value, Issued 951M USD +13.2%
Weighted Average Number of Shares Outstanding, Basic 130M shares +22.8%
Weighted Average Number of Shares Outstanding, Diluted 130M shares +22.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 111M USD +202%
Research and Development Expense 140M USD +13.5%
General and Administrative Expense 54.6M USD +9.64%
Operating Income (Loss) -83.7M USD +38.6%
Nonoperating Income (Expense) 9.53M USD +67.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -74.2M USD +43.2%
Income Tax Expense (Benefit) -677K USD -199%
Net Income (Loss) Attributable to Parent -73.5M USD +44%
Earnings Per Share, Basic -0.56 USD/shares +56.3%
Earnings Per Share, Diluted -0.56 USD/shares +56.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 154M USD -11%
Cash, Cash Equivalents, and Short-term Investments 122M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.29M USD
Other Assets, Current 4.68M USD +71.9%
Assets, Current 172M USD -6.84%
Property, Plant and Equipment, Net 11.8M USD -21.4%
Operating Lease, Right-of-Use Asset 20.3M USD -18%
Assets 209M USD -9.2%
Accounts Payable, Current 18.1M USD +46.6%
Employee-related Liabilities, Current 7.44M USD +7.79%
Accrued Liabilities, Current 2.21M USD -17%
Contract with Customer, Liability, Current 137M USD +23.4%
Liabilities, Current 173M USD +23.5%
Contract with Customer, Liability, Noncurrent 9.58M USD -90.8%
Operating Lease, Liability, Noncurrent 21.7M USD -24.8%
Other Liabilities, Noncurrent 190K USD
Liabilities 204M USD -25.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -279K USD -86%
Retained Earnings (Accumulated Deficit) -1.09B USD -7.23%
Stockholders' Equity Attributable to Parent -3.48M USD +93.3%
Liabilities and Equity 209M USD -9.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.4M USD -139%
Net Cash Provided by (Used in) Financing Activities 14.5M USD -58.6%
Net Cash Provided by (Used in) Investing Activities -417K USD +14.7%
Common Stock, Shares, Issued 122M shares +24.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -19.4M USD -116%
Deferred Tax Assets, Valuation Allowance 247M USD +9.25%
Deferred Tax Assets, Gross 253M USD +8.42%
Operating Lease, Liability 32.1M USD -14.6%
Depreciation 1.04M USD -27.3%
Payments to Acquire Property, Plant, and Equipment 417K USD -14.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -73.6M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid 38.4M USD -18.4%
Property, Plant and Equipment, Gross 55.8M USD +1.2%
Operating Lease, Liability, Current 7.16M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.59M USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.31M USD +7.58%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.24M USD -33.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.58M USD -0.07%
Deferred Tax Assets, Operating Loss Carryforwards 173M USD +8.92%
Unrecognized Tax Benefits 15.8M USD +13.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.99M USD -6.23%
Additional Paid in Capital 136M USD +8.83%
Deferred Tax Assets, Net of Valuation Allowance 6.19M USD -16.6%
Share-based Payment Arrangement, Expense 2.88M USD +4.76%